Sympathomimetic drug abuse masking an endogenous hyperadrenergic state, Graves' disease.
Sympathomimetic drug use or abuse in a thyrotoxic individual can be clinically devastating as a result of enhanced cellular sensitivity to adrenergic stimulation. Thus, it is critical to recognize thyrotoxicosis in a patient with coexistent sympathomimetic drug abuse. This case report describes a patient with Graves' disease and severe hyperadrenergic symptomatology that was thought to result from sympathomimetic drug abuse.
Jacobson
T
T
University of Nevada School of Medicine, Las Vegas.
Steckler
T
T
Wilson
B E
BE
D000293:Adolescent; D000662:Amphetamines / Q000009:adverse effects; D001143:Arousal / Q000187:drug effects; D003042:Cocaine / Q000009:adverse effects; D003937:Diagnosis, Differential; D006111:Graves Disease / Q000175:diagnosis*; D006801:Humans; D008297:Male; D009460:Neurologic Examination / Q000187:drug effects; D015813:Substance Abuse Detection; D019966:Substance-Related Disorders / Q000175:diagnosis*; D013566:Sympathomimetics / Q000009:adverse effects; D013971:Thyrotoxicosis / Q000175:diagnosis*
D000662:Amphetamines; D013566:Sympathomimetics; D003042:Cocaine